• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EPIX THERAPEUTICS DIAMONDTEMP¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EPIX THERAPEUTICS DIAMONDTEMP¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number CEDTB400L
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Fatigue (1849); Hematoma (1884); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Pain (1994)
Event Date 11/03/2022
Event Type  Injury  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported that during a radiofrequency (rf) ablation procedure, bleeding occurred at the femoral puncture site requiring no particular action.The case was completed with radiofrequency.Post-operatively, the patient was anemic and symptomatically hypotensive.Intravenous fluids were given.An infracentimetric hematoma at the scarpa triangle was observed on a doppler.There was no active bleeding from the hematoma at the puncture site.An ultrasound was performed and confirmed there was no pericardial effusion.The patient was discharged the following day.Five days later, the patient returned with a sudden onset of pain.A large, bulging hematoma opposite of the right inguinal puncture site was observed.The patient's pain was treated with analgesics.A blood test showed no deglobulation.An abdominal and pelvic scan revealed hematoma of the right pectineal muscle with minimal active arterial bleeding.The patient returned home the same day with instructions to ice the affected area.Four days later, an external echo-doppler was performed and the patient was hospitalized due to increased pain "disabling walking," decreased appetite, and fatigue.A compression test under ultrasound guidance showed volumetric increase of the hematoma in the right pectineal muscle and the underlying active art erial bleeding.Two days into the patient's hospitalization, a computerized tomography (ct) scan showed volumetric stability of the hematoma without signs of residual active bleeding.The patient was discharged the following day.The patient is a participant in a clinical study. no further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDTEMP¿
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
EPIX THERAPEUTICS
945 stewart drive
suite 100
sunnyvale CA 94085
Manufacturer (Section G)
EPIX THERAPEUTICS
945 stewart drive
suite 100
sunnyvale CA 94085
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15979578
MDR Text Key305466053
Report Number3015180993-2022-00040
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P200028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/10/2023
Device Model NumberCEDTB400L
Device Catalogue NumberCEDTB400L
Device Lot Number0000226198
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2022
Date Device Manufactured05/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-